FDA Cleared New Spinal Fusion Device for Low Bone Density
Patients with poor bone quality now have a new option for spinal fixation aimed at reducing screw loosening.
Updated on Sept. 28, 2026 in Arthritis
Live Poll
Do you believe new medical technology typically leads to better health outcomes for patients?
The U.S. Food and Drug Administration has granted 510(k) clearance to the iFuse Granite Onyx System. This device is specifically designed to provide stability for patients with low bone density undergoing spinal fusion procedures.
Why it matters
Spinal fusion constructs often face challenges with loosening at the upper and lower instrumented vertebrae, which occurs in 27% of cases. This new system offers an alternative for patients with poor bone quality who historically had limited surgical fixation options.
A 27% complication rate for loosening at the upper and lower instrumented vertebrae serves as the baseline for this new surgical hardware. The device utilizes a 3D-printed bone integration platform to address these known fixation limitations.
The players
U.S. Food and Drug Administration
The federal agency responsible for protecting public health by ensuring the safety and efficacy of medical devices.
SI-BONE
A medical device company based in Santa Clara, California, that specializes in surgical solutions for spinal and orthopedic conditions.
The details
The iFuse Granite Onyx System employs a bone-density-specific surface and anatomy-specific thread form to improve contact within the vertebrae. By using a 3D-printed platform designed for rapid osseointegration, the device aims to minimize micromotion at the site of the fusion. This process is engineered to secure early fixation, providing a more reliable foundation for patients whose bone quality might otherwise jeopardize the structural integrity of the fusion.
Timeline
2009: SI-BONE began supporting physician procedures.
September 28, 2026: The FDA granted 510(k) clearance for the iFuse Granite Onyx system.
Health Landscape
This development follows the pattern set by the SI-BONE clinical research program, which has already produced 190 peer-reviewed publications and four randomized controlled trials. It represents a shift toward more specialized hardware designed to accommodate specific physiological constraints like low bone density.
If you are considering spinal fusion and have concerns about low bone density, this device may be a topic worth discussing with your orthopedic surgeon. Your physician can evaluate whether your bone quality profile makes you a candidate for this specific fixation technology.
The takeaway
Loosening at the site of spinal instrumentation is a known complication that can affect nearly one in three patients. Patients considering surgery should ask their specialists about the specific hardware planned for their procedure and how it addresses individual bone density concerns.
Further reading
For more on managing degenerative spine conditions, visit the Arthritis section.
More information
Learn more about these surgical technologies on the SI-BONE company information and products portal.
Live Poll
Do you believe new medical technology typically leads to better health outcomes for patients?
